OWENS DAVID (Chief Medical Officer) purchased 0.7% of their position (1K shares) of NEXALIN TECHNOLOGY, INC. on the open market
Open‑market purchase worth $3.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/4/2025ACC: 0001829126-25-000672
DirectorOfficer· Chief Medical Officer
Since Sep 2022
+1K
Net shares
Net buyer
$3.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+1K
Price / share
$2.98
Trade value
$2.98K
% of position
0.7%
2/4/2025
153.79K→154.79K
Total
Net shares
+1K
Net value
$2.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 2/4/2025 | P · Purchase | +1K | $2.98 | $2.98K | 0.7% | 153.79K | 154.79K |
| Total | +1K | $2.98K | ||||||
Derivative Transactions0
No derivative transactions reported